Novavax Q4 Earnings Review: Long-Term Downsizing Plan Suggests Sell Rating
Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...
STAT12h
Turbulence at the FDA & bluebird Bio’s sale
FDA reform needs to be underpinned by strategy, not ‘indiscriminate’ cuts The Trump administration could save the lives of ...
Victims say their lives have been destroyed by Covid vaccine syndrome
Dozens of suspected victims of post-vaccination syndrome linked to Covid jabs have shared with MailOnline how their lives ...
New vaccine approved in over-60s - jab uses mRNA technology like Covid
The vaccine, manufactured by US pharmaceutical giant Moderna, was found to slash the risk of severe illness from respiratory ...
Disrupted US vaccine meetings could threaten timelines, access and transparency around shots
Two long-planned vaccine meetings — one at the US Centers for Disease Control and another at the US Food and Drug ...
COVID vaccine provided some protection this winter, estimates suggest
Few Minnesotans sought the COVID-19 vaccine to reduce their infection risks this winter, but at least the shots offered some ...
COVID pandemic inspires drug and vaccine discoveries
(WIFR) - 2025 marks five years since the deadly COVID-19 pandemic and research shows it impacted how drugs and vaccines are discovered. Phil Mounteney, who is Dotmatics' vice president of science and ...
The European Medicines Agency EMA has not 'admitted' that mRNA vaccines are 'experimental'
A false claim is circulating online that the European Medicines Agency (EMA) has acknowledged that mRNA vaccines have not ...